Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Thrombin/trypsin inhibitors from Oscillatoria agardhii

June 14, 1996

FDA allows initiation of clinical trials on Autologous Fibrinogen Delivery (AFD) kit

June 7, 1996

Genetics Institute readies factor IX marketing application

June 7, 1996

Cor Therapeutics' NDA for Integrilin faces FDA review

June 7, 1996

Gea claims antiplatelet and fibrinolytic compounds

June 7, 1996

PharmaGenics discloses oligonucleotides

June 7, 1996

Thrombin inhibitors claimed by Boehringer Mannheim

May 31, 1996

Tirofiban advances through clinical trials; filing in sight

May 24, 1996

IND filing anticipated for TBC-1269

May 24, 1996

VCAM-1/VLA-4 inhibitors in the Texas Biotechnology pipeline

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...